- Research works
- 1 fractional, all time
- Citations
- 45 58.4 per fractional work
- Top-10% rate
- 75.0% record average 16.5%
- Open access
- 100% world 28%
Not ranked overall: mAbDx (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does mAbDx (United States) publish most on?
By volume in 2022–2025: Mitochondrial Function and Pathology, Genetic Neurodegenerative Diseases, Parkinson's Disease Mechanisms and Treatments and Metabolism and Genetic Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Mitochondrial Function and Pathology Molecular Biology 0 works
- 2 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
- 3 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
- 4 Metabolism and Genetic Disorders Clinical Biochemistry 0 works
- 5 RNA modifications and cancer Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has mAbDx (United States)'s research output changed?
Other research institutions in Eugene
- University of Oregon
- Oregon Research Institute
- Oregon Social Learning Center
- Eugene Research Institute
- Decision Research
- Radiology Associates
- Science Factory
- NeuroSpine Institute
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.